Rockwell Medical Inc. is a publicly traded pharmaceutical drug company that is headquartered in Michigan. On March 23rd, 2018, the NASDAQ halted trading of Rockwell Medical Inc. after the company abruptly terminated its CEO. The CEO, Robert Chioini, is challenging his dismissal.
At Sonn Law Group, our investment fraud lawyers are currently investigating Rockwell Medical. If you are an investor who has lost a considerable amount of money in this company, you may be entitled to financial compensation for your damages.
Investigation: Rockwell Medical Inc.
After an internal dispute, Rockwell Medical Inc. terminated its CEO Robert Chioini. Mr. Chioini disputes the company’s authority to take such an action. Indeed, he is still holding himself out as a CEO of the company. This has caused tremendous confusion. Rockwell Medical and Mr. Chioini have released conflicting press statements, making it very difficult for investors to understand what is going on.
NASDAQ was forced to temporarily halt trading. Questions are now being raised over whether or not the company, its board, and former CEO Mr. Chioni have breached the fiduciary duty owed to investors. This case demands additional investigation so that more clarity can be brought to all customers who own securities in Rockwell Medical.
Contact Our Investment Fraud Attorneys Now
At Sonn Law Group, our law firm is dedicated to serving investors nationwide. If you or a family member sustained serious investment losses as a result of possible fraud or negligence, we can help. Contact us today for a free consultation.
Disclaimer: This article contains opinions and NOT statements of fact in any way whatsoever. The information here is general information that should not be taken as legal advice. NO attorney-client relationship is established between you and our attorneys by reading this article. This article is attorney advertising and should not be used as a substitute for legal advice from a qualified securities lawyer.